Research Now launches diabetes panel
The panel gives access to over 336,000 panelists in the US and Canada who have been diagnosed with either type 1 diabetes, type 2 diabetes, high blood pressure or obesity and aims to provide a resource for creating in-depth, multi-country insights on consumer ailment.
It is the first market research panel based around therapeutic areas to be launched by the company which will be rolling out a series of condition-based panels over the next twelve months.
Research Now senior vice-president of global healthcare Vincent DeRobertis said: “Our goal for this series is to be able to approach each condition uniquely, and focus on holistic solutions that will provide a deeper knowledge base of the condition.”
We hope you enjoyed this article.
Research Live is published by MRS.
The Market Research Society (MRS) exists to promote and protect the research sector, showcasing how research delivers impact for businesses and government.
Members of MRS enjoy many benefits including tailoured policy guidance, discounts on training and conferences, and access to member-only content.
For example, there's an archive of winning case studies from over a decade of MRS Awards.
Find out more about the benefits of joining MRS here.
0 Comments